Neuropeptide Y: Neurotransmitter or trophic factor in the heart?

News in Physiological Sciences

Volumn 18, Issue 5, 2003, Pages 181-185

  Protas, Lev ^a   Qu, Jihong ^a   Robinson, Richard B ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE Y; NEUROTRANSMITTER;

ANGIOGENESIS; AUTONOMIC NERVOUS SYSTEM; CALCIUM CHANNEL L TYPE; HEART; HEART VENTRICLE HYPERTROPHY; HUMAN; ION CHANNEL; NERVE ENDING; NONHUMAN; PACEMAKER; REVIEW; SYMPATHETIC NERVE CELL;

EID: 0242353217     PISSN: 08861714     EISSN: None     Source Type: Journal    
DOI: 10.1152/nips.01437.2003     Document Type: Review

References (20)

1. Balasubramaniam A. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 18: 445-457, 1997.
2. Bell D, Allen AR, Kelso EJ, Balasubramaniam A, and McDermott BJ. Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload. J Pharmacol Exp Ther 303: 581-591, 2002.
3. Bryant SM and Hart G. Effects of neuropeptide Y on L-type calcium current in guinea-pig ventricular myocytes. Br J Pharmacol 118: 1455-1460, 1996.
4. Chang F, Yu H, and Cohen IS. Actions of vasoactive intestinal peptide and neuropeptide Y on the pacemaker current in canine Purkinje fibers. Circ Res 74: 157-162, 1994.
5. Goldberg Y, Taimor G, Piper HM, and Schluter KD. Intracellular signaling leads to the hypertrophic effect of neuropeptide Y. Am J Physiol Cell Physiol 275: C1207-C1215, 1998.
6. Hansel DE, Eipper BA, and Ronnett GV. Neuropeptide Y functions as a neuroproliferative factor. Nature 410: 940-944, 2001.
7. Lathrop DA and Spooner PM. On the neural connection. J Cardiovasc Electrophysiol 12: 841-844, 2001.
8. Maki T, Gruver EJ, Davidoff AJ, Izzo N, Toupin D, Colucci W, Marks AR, and Marsh JD. Regulation of calcium channel expression in neonatal myocytes by catecholamines. J Clin Invest 97: 656-663, 1996.
9. Millar BC, Schluter KD, Zhou XJ, McDermott BJ, and Piper HM. Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes. Am J Physiol Cell Physiol 266: C1271 -C1277, 1994.
10. Millar BC, Weis T, Piper HM, Weber M, Borchard U, McDermott BJ, and Balasubramaniam A. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes. Am J Physiol Heart Physiol 261: H1727-H1733, 1991.
11. Moise NS. Inherited arrhythmias in the dog: potential experimental models of cardiac disease. Cardiovasc Res 44: 37-46, 1999.
12. Ogawa S, Barnett JV, Sen L, Galper JB, Smith TW, and Marsh JD. Direct contact between sympathetic neurons and rat cardiac myocytes in vitro increases expression of functional calcium channels. J Clin Invest 89: 1085-1093, 1992.
13. Ca,L postnatally (Abstract). Circulation 106: II-90, 2002.
14. Protas L and Robinson RB. Chronic neuropeptide Y exposure increases L-type Ca current in neonatal rat cardiomyocytes. Am J Physiol Heart Physiol 277: H940-H946, 1999.
15. f) in rat ventricles. J Physiol 526: 561-569, 2000.
16. Robinson RB. Autonomic receptor-effector coupling during post-natal development. Cardiovasc Res 31: E68-E76, 1996.
17. 1 adrenergic responsiveness. Am J Physiol Heart Circ Physiol 261: H969-H973, 1991.
18. Xiang H and Brown JC. Inhibitory effect of neuropeptide Y and its analogues on inositol 1,4,5-trisphosphate level in rat cardiomyocytes. Receptors Channels 1: 315-321, 1993.
19. Zeng C, Zhou Y, Liu G, and Sun W. The signal transduction pathway causing the synergistic hypertrophic effects of neuropeptide Y and norepinephrine on primary cardiomyocyte. Neuropeptides 35: 211-218, 2001.
20. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E, and Grant DS. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83: 187-195, 1998.